MoneyWorks4Me

Bharat Parenterals - Quaterly Results

12 May 2025 Evaluate
The Revenue for the quarter ended  March 2025 of Rs. 802.80 millions grew by 22.30 % from Rs. 656.40 millions.Net profit declined -25.73% to Rs. 22.80 millions from Rs. 30.70 millions.The company reported a degrowth in operating Profit to 68.50 millions from 69.80 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 802.80 656.40 22.30 3041.30 2579.80 17.89 3041.30 2579.80 17.89
Other Income 22.60 32.40 -30.25 145.50 80.40 80.97 145.50 80.40 80.97
PBIDT 68.50 69.80 -1.86 481.50 410.00 17.44 481.50 410.00 17.44
Interest 14.80 10.90 35.78 47.90 38.00 26.05 47.90 38.00 26.05
PBDT 53.70 58.90 -8.83 433.60 372.00 16.56 433.60 372.00 16.56
Depreciation 18.20 16.10 13.04 70.50 64.00 10.16 70.50 64.00 10.16
PBT 35.50 42.80 -17.06 363.10 308.00 17.89 363.10 308.00 17.89
TAX 12.70 12.10 4.96 98.60 82.10 20.10 98.60 82.10 20.10
Deferred Tax -0.50 -3.90 -87.18 -7.20 -4.50 60.00 -7.20 -4.50 60.00
PAT 22.80 30.70 -25.73 264.50 225.90 17.09 264.50 225.90 17.09
Equity 68.90 58.20 18.38 68.90 58.20 18.38 68.90 58.20 18.38
PBIDTM(%) 8.53 10.63 -19.76 15.83 15.89 -0.38 15.83 15.89 -0.38
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..